Andrew D. Skibo

AstraZeneca

Head of Global Biologics Operations

Andrew D. Skibo is Head of Global Biologics Operations for AstraZeneca. He has more than 40 years of experience in international pharmaceutical work in both small molecule and biologics, including 35 years specifically in biologics.  He has related experience with both operating companies (Amgen, Genentech, and Monsanto) and large international engineering and construction firms specializing in this business (Foster Wheeler, Life Sciences International, Fluor). 

He served as Chairman of the Board and as a member of the Executive Committee of the International Society for Pharmaceutical Engineering (ISPE). He is Past Chairman of the Global Pharmaceutical Manufacturing Leadership Forum.  He has published or presented more than 80 articles in this field and is a sought-after keynote speaker.  He holds a master of science degree in chemical engineering and a bachelor of science degree in chemistry, both from the Massachusetts Institute of Technology.